Plenty of evidence suggested that Bcl-xL-dependent apoptotic inhibition was the main reason that promoted chemotherapy resistance in tumours in vitro and vivo (Table 2) [123, 124]. This evidence concerns the gene BCL2L1 and neoplasm.